Mice Model Market is predicted to reach USD 2.4 billion at a CAGR of 6.20% during the forecast period 2023-2032

Market Research Future (MRFR) has published on the “Global Mice Model Market”.

The Mice Model market is estimated to register a CAGR of 6.20% during the forecast period of 2024 to 2032.

MRFR recognizes the following companies as the key players in the global Mice Model market— Charles River Laboratories International, Inc., Taconic Biosciences, Inc., The Jackson Laboratory, Envigo, JANVIER Labs, genOway S.A., Horizon Discovery Group plc, Harbour BioMed, Crown Bioscience Inc., InVivos Pte Ltd. and Others.

Market Highlights

The global Mice Model market is accounted to register a CAGR of 6.20% during the forecast period and is estimated to reach USD 2.4 billion by 2032.

The Mice Model market is experiencing growth due to several factors. Mice are widely used in biomedical research due to their genetic similarity to humans and ease of breeding and maintenance. Additionally, advancements in genetic engineering technologies have enabled the development of genetically modified mouse models, enhancing their utility in studying human diseases and drug discovery. Moreover, increasing investments in biomedical research and rising demand for personalized medicine further drive market expansion.

Access Full Report @ https://www.marketresearchfuture.com/reports/mice-model-market-21972

Segment Analysis

The global Mice Model market has been segmented based Model Type & Service, Technology, Therapeutic Area, Application and End User.

On the basis of Model Type & Service, the market is segmented into Model Type (Inbred Mice, Genetically Engineered Mice, Hybrid/Congenic Mice, Outbred Mice), Service (Breeding, Cryopreservation, Rederivation, Quarantine and Other services). The Model Type segment captured the largest market share in the Mice Model Market in 2023 due to its comprehensive offerings. This segment provides a wide range of mouse models, including genetically engineered, inbred, outbred, and hybrid models, along with related services such as breeding, genotyping, and phenotyping. The availability of diverse models and services caters to various research needs, contributing to its market dominance.

Based on Technology, the global Mice Model market has been segmented into CRISPR/CAS9, Microinjection, Embryonic Stem Cell Injection, Nuclear Transfer and Other Technologies. The CRISPR/CAS9 segment captured the largest market share in the Mice Model Market in 2023 due to its revolutionary impact on genetic engineering. This technology enables precise and efficient manipulation of mouse genomes, facilitating the creation of customized mouse models with desired genetic modifications. Its versatility, cost-effectiveness, and widespread adoption by researchers contributed to CRISPR/CAS9 Technology's dominance in the market.

Based on Therapeutic Area, the global Mice Model market has been segmented into Oncology, Metabolic Diseases, Immunology, Neurology, Cardiovascular Diseases and Other Therapeutic Diseases. The Oncology segment captured the largest market share in the Mice Model Market in 2023 due to the high demand for mouse models in cancer research. Mice models are extensively used to study tumor biology, evaluate therapeutic interventions, and develop new cancer treatments. The complexity and heterogeneity of cancer make mice models invaluable tools for advancing oncology research, driving their dominance in the market.

Based on application, the global Mice Model market has been segmented into Drug Discovery & Development, Research Application and Personalized Medicine. The Drug Discovery & Development segment captured the largest market share in the Mice Model Market in 2023 due to the extensive use of mouse models in preclinical drug testing. Mice are valuable tools for evaluating drug efficacy, toxicity, and pharmacokinetics, enabling researchers to identify promising drug candidates and optimize treatment regimens. The reliability and predictive value of mouse models in drug development contribute to their market dominance.

Based on End User, the global Mice Model market has been segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and CROS & CDMOS. The Pharmaceutical & Biotechnology Companies segment captured the largest market share in the Mice Model Market in 2023 due to their extensive utilization of mouse models in preclinical research and drug development. These companies rely on mouse models to assess drug efficacy, safety, and pharmacokinetics, facilitating the identification and optimization of novel therapeutics. Moreover, the need for personalized medicine drives the demand for customized mouse models, further consolidating their market dominance.

Regional Analysis

The global Mice Model market, based on region, has been divided into North America, Europe, Asia-Pacific, and Rest of the World. North America consists of the US and Canada. The Europe Mice Model market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The Mice Model market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World Mice Model market comprises the Middle East, Africa, and Latin America.

North America dominated the Mice Model Market due to factors such as a strong presence of pharmaceutical and biotechnology companies, well-established research infrastructure, and significant investments in biomedical research. Additionally, supportive regulatory frameworks, extensive collaborations between academia and industry, and a high demand for genetically modified mouse models contributed to North America's leadership in the market.

Europe secured the second-largest market share in the Mice Model Market due to factors such as a robust biomedical research ecosystem, well-established pharmaceutical and biotechnology industries, and supportive regulatory environments. Additionally, Europe benefits from a strong network of academic and research institutions, extensive collaborations between academia and industry, and growing investments in genetic engineering technologies, contributing to its prominence in the market.

Asia Pacific is experiencing the highest compound annual growth rate (CAGR) in the Mice Model Market due to factors such as increasing investments in biomedical research, expanding pharmaceutical and biotechnology industries, and rising adoption of mouse models in preclinical studies. Moreover, the region's growing emphasis on personalized medicine and advancements in genetic engineering technologies contribute to its significant growth potential in the market.

Furthermore, the rest of the world's Mice Model market is divided into the Middle East, Africa, and Latin America. The rest of the world is witnessing growth in the Mice Model market due to factors such as expanding biomedical research infrastructure, rising investments in pharmaceutical and biotechnology sectors, and increasing collaborations with global research institutions, driving the demand for mouse models in preclinical studies.

Key Findings of the Study

• The global Mice Model market is expected to reach USD 2.4 billion by 2032, at a CAGR of 6.20% during the forecast period.


• The Asia Pacific region is experiencing rapid growth in the Mice Model market due to increasing investments in biomedical research, expanding pharmaceutical and biotechnology industries, and rising adoption of mouse models.


• Based on Technology, the CRISPR/CAS9 segment was attributed to holding the largest market in 2023, with an approximate market share of 20–40%.


• Charles River Laboratories International, Inc., Taconic Biosciences, Inc., The Jackson Laboratory, Envigo, JANVIER Labs, genOway S.A., Horizon Discovery Group plc, Harbour BioMed, Crown Bioscience Inc., InVivos Pte Ltd. and Others are the key market players.